Search For "biotech"
Covid-19: No newborn calf serum in final Covaxin product, says Health mini
Updated : 4 years, 9 months ago IST
New Delhi [India], June 16 (ANI): The Union Health Ministry on Wednesday said that newborn calf serum is not an ingredient of the final Covaxin vaccine by Bharat Biotech.
Read More
Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre's
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 15 (ANI): Indigenous COVID-19 vaccine maker Bharat Biotech on Tuesday said the supply price of Covaxin to the Government of India at Rs 150 per dose is a non-competitive price and not sustainable in the long run, hence a higher price in private markets is
Read More
Novavax's vaccine, also produced by SII, found 90 pc effective against COV
Updated : 4 years, 9 months ago IST
New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine provides 100 per cent protection against moderate and severe symptoms of the disease and 90.4 per cent efficacy overall in phase 3 trials.
Read More
AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials f
Updated : 4 years, 9 months ago IST
New Delhi [India], June 14 (ANI): The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.
Read More
Bharat Biotech to undertake clinical trials in US
Updated : 4 years, 9 months ago IST
New Delhi [India], June 12 (ANI): India's first indigenous COVID-19 vaccine manufacturer Bharat Biotech on Saturday said that it will be carrying out clinical trials in the US to support the marketing application for Covaxin in the country.
Read More
Bharat Biotech shares full data of all research studies of Covaxin
Updated : 4 years, 9 months ago IST
New Delhi [India], June 12 (ANI): Bharat Biotech on Saturday shared full data of all research studies of its Covaxin-- India's first indigenous COVID-19 vaccine.
Read More
Vaccination drive for 18+ has started at Dana Shivam Hospital Jaipur
Updated : 4 years, 9 months ago IST
Jaipur (Rajasthan) [India], June 12 (ANI/PNN): Dana Shivam Heart and Super-specialty Hospital in Jaipur has started vaccination drive, for age bracket of 18 years old and above, at their hospital in Jaipur.
Read More
We respect US FDA decision, but it won't impact India's vaccine plan: Cent
Updated : 4 years, 9 months ago IST
New Delhi [India], June 11 (ANI): Reacting to the United States Food and Drug Administration (FDA)'s rejection of Bharat Biotech's Covaxin jab for emergency use authorization, the Union Health Ministry on Friday said that it respects the decision taken by the authority but it will not hav
Read More
Vaccines are working against infection, severe disease of COVID-19, reveal
Updated : 4 years, 9 months ago IST
New Delhi [India], June 11 (ANI): Christian Medical College, Vellore, a 2,600 bed tertiary care hospital in India with 10,600 employees has vaccinated 84.8 per cent staff with majority of them getting Covishield and rest received Covaxin by Bharat Biotech, a latest research done on health
Read More
Bharat Biotech's US partner, Ocugen to apply for full approval for Covaxin
Updated : 4 years, 9 months ago IST
Pennsylvania [US], June 11 (ANI): Bharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA) for COVAXIN and the US Food and Drug Administration (FDA) has recommended that the company go for the Biologics Licence Application (BL
Read More
Researchers find algorithm to better CRISPR gene editing
Updated : 4 years, 9 months ago IST
Washington [US], June 10 (ANI): While researchers had first engineered CRISPR as a gene-editing technology for bacterial, plant, animal and human cells it eventually became a Nobel prize-winning revolution. The technology's potential spans from curing genetically disposed diseases to applica
Read More
COVAXIN phase 3 full trial data will be made public in July: Bharat Biotec
Updated : 4 years, 9 months ago IST
New Delhi [India], June 9 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of COVAXIN.
Read More